Researchers are creating tools to estimate fracture risk in giant-breed dogs with osteosarcoma as well as evaluating a novel method to stabilize the affected bone.
Researchers will use serum samples from dogs enrolled in the Golden Retriever Lifetime Study to look for early markers of lymphoma before overt disease.
Researchers will investigate a novel nanoparticle system to deliver chemotherapy drugs directly to osteosarcoma tumors, the most common bone cancer in dogs.
Researchers will conduct a clinical trial investigating the safety and anticancer effectiveness of trametinib, a drug to treat companion dogs with aggressive cancers.